116 related articles for article (PubMed ID: 12927653)
1. Drug and alcohol treatment among privately insured patients: rate of specialty substance abuse treatment and association with cost-sharing.
Stein BD; Zhang W
Drug Alcohol Depend; 2003 Aug; 71(2):153-9. PubMed ID: 12927653
[TBL] [Abstract][Full Text] [Related]
2. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions.
Dave D; Mukerjee S
Health Econ; 2011 Feb; 20(2):161-83. PubMed ID: 20029912
[TBL] [Abstract][Full Text] [Related]
3. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care.
Stein B; Orlando M; Sturm R
Psychiatr Serv; 2000 Feb; 51(2):195-8. PubMed ID: 10655002
[TBL] [Abstract][Full Text] [Related]
4. Short term drug abuse treatment costs and utilization: a multi-employer analysis.
Goodman AC; Nishiura E; Hankin JR
Med Care; 1998 Aug; 36(8):1214-27. PubMed ID: 9708593
[TBL] [Abstract][Full Text] [Related]
5. The effect of parity-induced copayment reductions on adolescent utilization of substance use services.
Ciemins EL
J Stud Alcohol; 2004 Nov; 65(6):731-5. PubMed ID: 15700510
[TBL] [Abstract][Full Text] [Related]
6. The sensitivity of substance abuse treatment intensity to co-payment levels.
Lo Sasso AT; Lyons JS
J Behav Health Serv Res; 2004; 31(1):50-65. PubMed ID: 14722480
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with the receipt of treatment following detoxification.
Mark TL; Dilonardo JD; Chalk M; Coffey R
J Subst Abuse Treat; 2003 Jun; 24(4):299-304. PubMed ID: 12867203
[TBL] [Abstract][Full Text] [Related]
8. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
9. Growth in spending on substance use disorder treatment services for the privately insured population.
Thomas CP; Hodgkin D; Levit K; Mark TL
Drug Alcohol Depend; 2016 Mar; 160():143-50. PubMed ID: 26781063
[TBL] [Abstract][Full Text] [Related]
10. The effects of expanded mental health benefits on treatment costs.
Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
[TBL] [Abstract][Full Text] [Related]
11. Considering health insurance parity for mental health and substance abuse treatment: the Federal Employees Health Benefits experience.
Goldman HH
Am J Psychiatry; 2007 Oct; 164(10):1473-4. PubMed ID: 17898334
[No Abstract] [Full Text] [Related]
12. Substance abuse benefits: still limited after all these years.
Gabel JR; Whitmore H; Pickreign JD; Levit KR; Coffey RM; Vandivort-Warren R
Health Aff (Millwood); 2007; 26(4):w474-82. PubMed ID: 17556380
[TBL] [Abstract][Full Text] [Related]
13. Patient cost-sharing and insurance arrangements are associated with hospital readmissions after abdominal surgery: Implications for access and quality health care.
Youn B; Soley-Bori M; Soria-Saucedo R; Ryan CM; Schneider JC; Haynes AB; Cabral HJ; Kazis LE
Surgery; 2016 Mar; 159(3):919-29. PubMed ID: 26477477
[TBL] [Abstract][Full Text] [Related]
14. Costs and utilization of substance abuse care in a privately insured population under managed care.
Schoenbaum M; Zhang W; Sturm R
Psychiatr Serv; 1998 Dec; 49(12):1573-8. PubMed ID: 9856619
[TBL] [Abstract][Full Text] [Related]
15. Cost sharing for substance abuse and mental health services in managed care plans.
Hodgkin D; Horgan CM; Garnick DW; Merrick EL
Med Care Res Rev; 2003 Mar; 60(1):101-16. PubMed ID: 12674022
[TBL] [Abstract][Full Text] [Related]
16. Cost-Sharing Disparities for Out-of-Network Care for Adults With Behavioral Health Conditions.
Xu WY; Song C; Li Y; Retchin SM
JAMA Netw Open; 2019 Nov; 2(11):e1914554. PubMed ID: 31693122
[TBL] [Abstract][Full Text] [Related]
17. Shifting to outpatient care? Mental health care use and cost under private insurance.
Leslie DL; Rosenheck R
Am J Psychiatry; 1999 Aug; 156(8):1250-7. PubMed ID: 10450268
[TBL] [Abstract][Full Text] [Related]
18. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
Buttorff C; Andersen MS; Riggs KR; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
[TBL] [Abstract][Full Text] [Related]
19. The effects of copayments on substance abuse treatment expenditures and treatment reoccurrence.
Lo Sasso AT; Lyons JS
Psychiatr Serv; 2002 Dec; 53(12):1605-11. PubMed ID: 12461223
[TBL] [Abstract][Full Text] [Related]
20. Inpatient treatment of comorbid psychiatric and substance abuse disorders: comparison of public sector and privately insured populations.
Leslie DL; Rosenheck R
Adm Policy Ment Health; 1999 Mar; 26(4):253-68. PubMed ID: 10431398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
